|
|
| Commercial Reasonableness of Physician Compensation Analytical Update(181001N) |
Course CPE: 2 hours
Field(s) of Study: Business Law–1 hour; Economics–1 hour
Program Level: Overview
Prerequisites: None
Delivery Method: Self-Study
Advanced Preparation: None |
Item
Number: 18HC1001CRPC
Shipping Weight: 0lbs. 0oz. |
| Price:
$147.00 |
|
|
|
|
Recording Date: October 1, 2018
Program Description
With recent healthcare reform initiatives, a major paradigm shift is taking place in the healthcare delivery system. The passage and implementation of Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), as well as legislative discussion regarding the viability and sustainability of current fraud and abuse laws, may significantly change the requisite analysis required to determine whether a physician compensation arrangement does not exceed fair market value and is a commercially reasonable transaction. This session will focus on the potential impact of MACRA and other reform initiatives on related changes in the methodology and analytical thresholds for the commercial reasonableness of physician compensation arrangements, and valuation professionals with the tools to understand and thrive in this paradigm shift.
Learning Objective
After completing this webinar, attendees will be able to:
- Articulate the various definitions of commercial reasonableness as promulgated by federal statutes, regulations, and case law
- Identify and describe the most recent federal fraud and abuse cases related to commercial reasonableness and physician compensation
- Describe the potential challenges surrounding the development of a commercial reasonableness analysis in the current volatile healthcare reimbursement environment, which is shifting payment from a volume-based to a value-based structure
Who should attend
Valuation professionals, attorneys, hospital and health system c-suite executives (e.g., CEOs, CFOs, COOs), and healthcare consultants
Presenter(s)
Todd Zigrang |
|
|
